Author Archives: Bernard Vrijens

Case for Measuring and Managing Patient Adherence

The Case for Measuring and Managing Patient Adherence

According to the World Health Organization, up to half of the patients with chronic diseases fail to take their medications properly.1 Research shows many patients who are part of clinical trials do not maintain medication adherence either.2 Among many things, poor patient adherence … Read More

Removing the Barriers that Hinder Patient Adherence in Trials

Removing the Barriers that Hinder Patient Adherence

Poor patient adherence tends to be a matter of people not taking their medicine as prescribed, due to access barriers. So how can placing an additional burden on patients be the answer?  As an industry, we are more than aware … Read More

AARDEX Group Joins Innovative IT4Anxiety Project

Innovative medication adherence tools in a real-world hospital setting to reduce anxiety in users of mental health services. Liege, Belgium – March 3, 2022: Belgium-based AARDEX Group, the global leader in Digital Tools for measuring and managing adherence to medication, today announced they have … Read More

EU Clinical Trials Regulation

EU Clinical Trials Regulation Creates a Framework for the Future of Research

Recent advances in medical science are providing new hope for people living with unmet needs – but modern medicines are only one side of the coin. Ensuring new treatments move from bench side to bedside as soon as possible is … Read More

smart packaging in clinical trials

Smart Packaging in Clinical Trials: The Missing Piece in the Medication Adherence Puzzle

Poor adherence to medication has been costing lives and money for decades – but cutting-edge solutions are now on hand to solve the age-old problem. It is no secret that the medical community has a problem with patient compliance: patients … Read More

Not all Medication Adherence Tools are Created Equal – A Case Study

It may hold the potential to solve one of healthcare’s biggest problems, but not all Medication Adherence Tools are created equal. The key to helping people to take their medicines as prescribed, whether within a clinical trial or as part … Read More

Poor Medication Adherence: A Dangerous yet Modifiable Risk Factor in Psychiatry and Oncology Trials

When it comes to medication adherence in psychiatry and oncology trials, the stakes are high – not taking medicines as prescribed can have life-altering or even life-threatening consequences. As such, we often assume almost perfect adherence. Unfortunately, this could not … Read More

When Participant Retention Diminishes, it’s Time to Invest in Participant Engagement

Boost clinical trial retention with participant engagement and adherence patterns Clinical trial participants are among a study’s most valuable assets – which is why Sponsors & CROs are increasingly investing to keep them on board, on track, and on the … Read More

Ensuring Optimal Medication Adherence Monitoring

Considerations for Ensuring Optimal Digital Adherence Monitoring

It’s no secret, recruiting clinical trial participants is difficult, time-consuming, and considerably expensive, all while dropout rates are notoriously high across therapeutic areas. Whatever the motive for dropout, the impact is huge. Trials can become underpowered and may not have … Read More

Mitigating the Risk of Trial Failure with Digital Adherence Monitoring

Drug development is inherently risky, with some analysis showing that just 13.8% of products that enter industry-sponsored Phase I trials go on to obtain FDA approval.1 Of course, the exact figure varies across therapy areas and development stages, but it is … Read More